uFraction8: Funding, Investors & Team (Sep 2026)
uFraction8 offers a scalable technology for bioprocessing that allows for the filtration, separation, and dewatering of biomass. It can be used with various microorganisms such as micro algae, yeast, and bacteria to separate biomass from the culture medium without causing harm and without the need for flocculants, unlike traditional methods such as centrifuges, filters, and membranes.
uFraction8 has raised $7.7M across 2 funding rounds on record, the most recent an undisclosed round of $4.3M announced in Feb 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
uFraction8 Company Profile and Key Stats
Latest funding round on record: Feb 2025.
uFraction8 Funding Rounds
uFraction8 raised $3.4M in a Seed announced in Jan 2022.
3.1 years later, an undisclosed round of $4.3M was announced in Feb 2025.
uFraction8 Founders and Leadership Team
Contact details for the uFraction8 team: 1 of 1 has an email address on file.
Start 14-day free trial →uFraction8 Funding Compared to Other Biotechnology Startups
uFraction8's latest round of $4.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like uFraction8 in Biotechnology and Falkirk
Companies Similar to uFraction8
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
uFraction8 Funding FAQs
What does uFraction8 do?
uFraction8 offers a scalable technology for bioprocessing that allows for the filtration, separation, and dewatering of biomass. It can be used with various microorganisms such as micro algae, yeast, and bacteria to separate biomass from the culture medium without causing harm and without the need for flocculants, unlike traditional methods such as centrifuges, filters, and membranes.
How much funding has uFraction8 raised?
uFraction8 has raised $7.7M across 2 rounds on record. The most recent is an undisclosed round of $4.3M announced in Feb 2025.
When did uFraction8 last raise funding?
uFraction8's most recent funding round on record is an undisclosed round of $4.3M, announced in Feb 2025.
Who founded uFraction8?
FundedIQ lists Monika Tomecka (Founder) at uFraction8.
Where is uFraction8 headquartered?
uFraction8 is based in Falkirk, United Kingdom.
How many employees does uFraction8 have?
uFraction8 is in the 1-10 employee band.
How does uFraction8's funding compare to other Biotechnology startups?
uFraction8's latest round of $4.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's uFraction8 Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for uFraction8 is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.